Alceus Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Alceus Bio General Information
Description
Developer of synthetic chimeric antigen receptor T-cell therapies designed for solid cancers. The company's platform utilizes a multimodal architecture and artificial intelligence to design peptide medicines that program immune cells to produce therapeutics directly in the body, enabling oncology patients to access treatments that address tumor resistance and target previously undruggable malignancies.
Contact Information
Website
www.alceus.bioCorporate Office
- Kreston Reeves Llp, 2nd Floor
- 168 Shoreditch High Street
- London E1 6RA
- England, United Kingdom
Corporate Office
- Kreston Reeves Llp, 2nd Floor
- 168 Shoreditch High Street
- London E1 6RA
- England, United Kingdom
Alceus Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jul-2025 | Completed | Startup | |||
| 1. University Spin-Out | 16-Oct-2024 | Completed | Startup |
Alceus Bio Signals
Alceus Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cancer Research Technology | Venture Capital | Minority | ||
| Vento (Venture Capital) | Venture Capital | Minority | ||
| Wilbe Capital | Venture Capital | Minority | ||
| University of Cambridge | University |
Alceus Bio FAQs
-
When was Alceus Bio founded?
Alceus Bio was founded in 2024.
-
Where is Alceus Bio headquartered?
Alceus Bio is headquartered in London, United Kingdom.
-
What is the size of Alceus Bio?
Alceus Bio has 3 total employees.
-
What industry is Alceus Bio in?
Alceus Bio’s primary industry is Drug Discovery.
-
Is Alceus Bio a private or public company?
Alceus Bio is a Private company.
-
What is Alceus Bio’s current revenue?
The current revenue for Alceus Bio is .
-
Who are Alceus Bio’s investors?
Cancer Research Technology, Vento (Venture Capital), Wilbe Capital, and University of Cambridge have invested in Alceus Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process